[Hepatopulmonary syndrome and portal hypertension]
- PMID: 17665669
[Hepatopulmonary syndrome and portal hypertension]
Abstract
Background: The hepatopulmonary syndrome is known by the association of chronic hepatopathy and refractory hypoxemia linked to pulmonary vasodilatation. The hepatopathy may be an hepatic cirrhosis, a congenital porto-case shunt, a porte cavernous angioma or a portal high blood pressure.
Aim: Report new cases
Case report: We report the observation of a girl followed from the age of 5 years for type I auto-immune hepatitis complicated of portal high blood pressure, in whom the hepatopulmonary syndrome appears 6 years later and the diagnosis was established in front of the presence of clinical signs (cyanosis and fingers clubbing) associated to a severe hypoxia at 43 mmHg without heart attack and in front of the results of scintigraphy use with albumine micro-agregat marked to technetium 99 m which objected an increase of perfusion at the lungs and an extra pulmonary fixation (cerebral, thyroïdien and renal). In front of the severity of hypoxia and the intensity of the extra pulmonary fixation which corresponds the importance of the shunts, the hepatic transplantation shouldn't be realized and the child followed only a salt-free diet associated to a martial addition and to treatment by propanolol.
Conclusion: The hepatopulmonary syndrome is a diagnosis to evocate in front of all hypoxia happening during the evolution of a chronic hepatopathy with portal high blood pressure. Its prognosis is severe in the absence of a hepatic transplantation.
Similar articles
-
A study of hepatopulmonary syndrome among patients of cirrhosis of liver and portal hypertension.Indian J Chest Dis Allied Sci. 2003 Jul-Sep;45(3):165-71. Indian J Chest Dis Allied Sci. 2003. PMID: 12866633
-
Hepatopulmonary Syndrome in children: a comparative study of non-cirrhotic vs. cirrhotic portal hypertension.Liver Int. 2015 Jun;35(6):1665-72. doi: 10.1111/liv.12708. Epub 2014 Nov 20. Liver Int. 2015. PMID: 25351435
-
Hepatopulmonary Syndrome, Severe Cyanosis and Marfanoid Habitus.J Assoc Physicians India. 2014 Dec;62(12):57-60. J Assoc Physicians India. 2014. PMID: 26259426
-
[The hepatopulmonary syndrome].Presse Med. 2002 Feb 16;31(6):271-80. Presse Med. 2002. PMID: 11883372 Review. French.
-
Hepatopulmonary syndrome and portopulmonary hypertension.Swiss Med Wkly. 2003 Mar 22;133(11-12):163-9. doi: 10.4414/smw.2003.10016. Swiss Med Wkly. 2003. PMID: 12715285 Review.
Cited by
-
Annexin A1 protein regulates the expression of PMVEC cytoskeletal proteins in CBDL rat serum-induced pulmonary microvascular remodeling.J Transl Med. 2013 Apr 15;11:98. doi: 10.1186/1479-5876-11-98. J Transl Med. 2013. PMID: 23587191 Free PMC article.
-
MiR145-5p inhibits proliferation of PMVECs via PAI-1 in experimental hepatopulmonary syndrome rat pulmonary microvascular hyperplasia.Biol Open. 2019 Nov 4;8(11):bio044800. doi: 10.1242/bio.044800. Biol Open. 2019. PMID: 31649116 Free PMC article.